# Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects

> **NCT02560688** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 22 (actual)

## Conditions studied

- Drug Interaction

## Interventions

- **DRUG:** DS-1040b
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02560688
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02560688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02560688, "Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02560688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*